2024-514661-19-01招募中1 期
A Phase 1, First-in-Human Study of MEN2312, a KAT6 inhibitor, as Monotherapy and in Combination in Participants with Advanced Breast Cancer
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 46
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development and Clinical Operations
Scientific
Stemline Therapeutics Inc.
研究点 (8)
Loading locations...
相似试验
招募中
1 期
First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients2025-521446-20-00Kamari Pharma Ltd.64
招募中
1 期
First-in-Human Study of RO78126532025-522101-37-00F. Hoffmann-La Roche AG12
招募中
1 期
A Phase 1/2 Study of Bleximenib in Participants with Acute LeukemiaAcute Leukemia2023-506581-31-00Janssen - Cilag International72
招募中
2 期
Study of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma2024-513098-31-00Ryvu Therapeutics S.A.118
招募中
1 期
RIVKAL clinical trial for the first-in-human administration of BIM2b in participants with GlioblastomaGlioblastoma2023-508662-15-00Beta Innov36